Apoptosis of human embryonal carcinoma cells with in vitro differentiation

Cell Structure and Function

Volumn 21, Issue 1, 1996, Pages 53-61

  Yamada, Taketo ^a   Suzuki, Nao ^a   Hiraoka, Nobuyoshi ^a   Matsuoka, Kentaroh ^a   Fukushima, Sachiko ^a   Hashiguchi, Akinori ^a   Hata, Jun Ichi ^a  

^a KEIO UNIVERSITY   (Japan)

Author keywords

Apoptosis; Cellular differentiation; Human embryonal carcinoma cell; Le(Y); Retinoic acid

Indexed keywords

DNA FRAGMENT; RETINOIC ACID;

APOPTOSIS; ARTICLE; BIOLOGICAL MODEL; CARCINOMA CELL; CELL DEATH; CELL DIFFERENTIATION; EMBRYO; EMBRYONAL CARCINOMA; FLOW CYTOMETRY; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

EID: 0029958790     PISSN: 03867196     EISSN: None     Source Type: Journal    
DOI: 10.1247/csf.21.53     Document Type: Article

References (36)

1. ABBADLE, C., KABRUN, N., BOUALI, F., SMARDOVA, M., STEHELLIN, D., VANDENBUNDER, B., and ENRIETTO, P. 1993. High level of c-rel expression are associated with programmed cell death in the developing avian embryo and in bone marrow cells in vitro. Cell, 75: 899-912.
2. Y Antigen in Human Immunodeficiency Virus-Infected Human T Cell Lines and in Peripheral Lymphogytes of Patients with Acquired Immune Deficiency Syndrome (AIDS) and AIDS-Related Complex (ARC). J. Exp Med., 167: 323-331.
3. ANDREWS, P.W., DAMJANOV, I., SIMON, D., BANTING, G.S., CARLIN, C., DRACOPOLI, N.C., and FOGH, J. 1984. Plulipotent embryonal carcinoma clones derived from the human teratocarcinoma cell line Tera-2. Lab. Invest., 50: 147-162.
4. BRACH, M., DEVOS, S., GRUSS, H.J., and HERRMANN, F. 1992. Prolongation of survival of human polymorphonuclear neutrophils by granulocyte macrophage colony-stimulating factor is caused by inhibition of programmed cell death. Blood, 80: 2920-2924.
5. COHEN, J. 1991. Programmed cell death in the immune system. Adv. Immunol., 50: 55-85.
6. FAIRBAIRN, L.J., COWLING, G.J., REOPERT, B.M., and DEXTER, T. 1993. Suppression of apoptosis allows differentiation and development of a multipotent hemopoietic cell line in the absence of added growth factors. Cell, 74: 823-832.
7. FANIDI, A., HARRINGTON, A.E., and EVAN, I. 1992. Cooperative interaction between c-myc and bcl-2 proto-oncogenes. Nature, 359: 554-556.
8. GAVRIELI, Y., SHERMAN, Y., and BEN-SASSON, S. 1992. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J. Cell Biol., 119: 493-501.
9. GRAMZINSKI, R.A., PARCHMENT, R.E., and PIERCE, G. 1990. Evidence linking programmed cell death in the blastocyst to polyamine oxidation. Differentiation, 43: 59-65.
10. HANDYSIDE, A.H. and HUNTER, S. 1986. Cell division and death in the mouse blastocyst before implantation. Roux's Archives of Developmental Biology., 195: 519-526.
11. HATA, J., FUJIMOTO, J., ISHII, E., UMEZAWA, A., KOKAI, Y., MATSUBAYASHI, Y., ABE, H., KUSAKARI, S., KIKUCHI, H., YAMADA, T., and MARUYAMA, T. 1992. Differentiation of human germ cell tumor cells in vivo and in vitro. Acta Histochem. Cytochem., 563-576.
12. HENGARTNER, M.O. and HORVITZ, H. 1994. Activation of C. elegans cell death protein CED-9 by an amino-acid substitution in a domain conserved in Bcl-2. Nature, 369: 318-320.
13. HENGARTNER, O.M. and HORVITZ, R. 1994. C. elegans cell survival gene ced-9 encodes a functional homolog of the mammalian proto-oncogene bcl-2. Cell, 76: 665-676.
14. Y antigen expression is correlated with apoptosis (programmed cell death). Glycobiol., 3: 381-390.
15. HOSLER, B.A., LAROSA, G.J., GRIPPO, J.F., and GUDAS, L.J. 1989. Expression of REX-1, a gene containing zinc finger motifs, is rapidly reduced by retinoic acid in F9 teratocarcinoma cells. Mol. Cell. Biol., 9: 5623-5629.
16. HUEBNER, K., LINNENBACH, A., WEIDNER, S., GLENN, G., and CROCE, C. 1981. Deoxyribonuclease I sensitivity of plasmid genomes in teratocarcinoma-derived stem and differentiated cells. Proc. Natl. Acad. Sci. USA, 78: 5071-5075.
17. KOSEKI, C., HERZLINGER, D., and AI-AWQATI, Q. 1992. Apoptosis in metanephric development. J. Cell Biol., 119: 1327-1333.
18. LUCAS, M., SOLANO, F., and SANZ, A. 1991. Induction of programmed cell death (apoptosis) in mature lymphocytes. FEBS letters, 279: 19-20.
19. MARTIN, S.J., LENNON, S.V., BONHAM, A.M., and COTTER, T. 1990. Induction of apoptosis (programmed cell death) in human leukemic HL-60 cells by inhibition of RNA or protein synthesis. J. Immunol., 145: 1859-1867.
20. NEIMAN, P.E., THOMAS, S.J., and LORING, G. 1991. Induction of apoptosis during normal and neoplastic B-cell development in the bursa of Fabricius. Proc. Natl. Acad. Sci. USA, 88: 5857-5861.
21. OKAMOTO, K., OKAZAWA, H., OKUDA, A., SAKAI, M., MURAMATSU, M., and HAMADA, H. 1990. A novel octamer binding transcription factor is differentially expressed in mouse embryonic cells. Cell, 60: 461-472.
22. PIERCE, G.B., LEWELLYN, A., and PARCHMENT, R.E. 1989. Mechanism of programmed cell death in the blastocyst. Proc. Natl. Acad. Sci. USA, 86: 3654-3658.
23. PIERCE, G.B., PARCHMENT, R.E., and LEWELLYN, L. 1991. Hydrogen peroxide as a mediator of programmed cell death in the blastocyst. Differentiation, 46: 181-186.
24. RAFF, M. 1992. Social controls on cell survival and cell death. Nature, 356: 397-400.
25. SACHS, L. and LOTEM, J. 1993. Control of programmed cell death in normal and leukemic cells: new inplicationn for therapy. Blood, 82: 15-21.
26. SAWAI, S., SHIMONO, A., HANAOKA, K., and KONDOH, H. 1991. Embryonic lethality resulting from disruption of N-myc alleles in mouse zygotes. New Biol., 3: 861-869.
27. SAWAI, S., SHIMOTO, A., WAKAMATSU, Y., PALMES, C., HANAOKA, K., and KONDOH, H. 1993. Defects of embryonic organogenesis resulting from targeted disruption of the N-myc gene in the mouse. Development, 117: 1445-1455.
28. SCHWARTZ, L. 1992. Insect muscle as a model for programmed cell death. J. Neurobiol., 23: 1312-1326.
29. SCHWARTZ, L.M., MYER, A., KOSZ, L., ENGELSTEIN, M., and MAIER, C. 1990. Activation of polyubiquitin gene expression during developmentally programmed cell death. Neuron, 5: 411-419.
30. TOMEI, L.D., SHAPIRO, J.P., and COPE, F. 1993. Apoptosis in C3H/10T1/2 mouse embryonic cells: evidence for internucleosomal DNA modification in the absence of double-strand cleavage. Proc. Natl. Acad. Sci. USA, 90: 853-857.
31. WILLIAMS, G.T., SMITH, C.A., SPOONCER, E., DEXTER, T.M., and TAYLOR, D.R. 1990. Haemopoietic colony stimulating factors promote cell survival by suppressing apoptosis. Nature, 343: 76-79.
32. WOLFF, T. and READY, D. 1991. Cell death in normal and rough eye mutants of drosophila. Development, 113: 825-839.
33. WYLLIE, A.H., MORRIS, R.G., SMITH, A.L., and DUNLOP, D. 1984. Chromatin cleavage in apoptosis: association with condensed chromatin morphology and dependence on macromolecular systhesis. J. Pathol., 142: 67-77.
34. YAMADA, T. and HATA, J. 1995. Simple and rapid method for detection of apoptotic cells by flow cytometry. Acta Histochem. Cytochem., 28: 277-280.
35. YIN, X.M., OTIVAL, Z.N., and KORSMEYER, S. 1994. BH1 and BH2 domains of Bcl-2 are required for inhibition of apoptosis and heterodimerization with Bax. Nature, 369: 321-323.
36. ZYCHLINSKY, A., ZHENG, L.M., LIU, C.C., and YOUNG, J. 1991. Cytolytic lymphocytes induce both apoptosis and necrosis in target cells. J. Immunol., 146: 393-400.